Национальная Медицинская Академия Последипломного Образования Им. П.Л. Шупика
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальная Медицинская Академия Последипломного Образования Им. П.Л. ШупикаfiledCriticalНациональная Медицинская Академия Последипломного Образования Им. П.Л. Шупика
Priority to UAU201312563UpriorityCriticalpatent/UA88080U/en
Publication of UA88080UpublicationCriticalpatent/UA88080U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The method for the medicamentous treatment following aortocoronary bypass surgery for preventing bypass stenosis provides for the conventional antianginal, antithrombotic and hypolipidemic therapy. Also, Valsartan as blocker of angiotensin receptor 2 is used at a daily dose of 160-320 mg.
UAU201312563U2013-10-282013-10-28Method for medicamentous treatment following aortocoronary bypass surgery for preventing bypass stenosis
UA88080U
(en)